corydine has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di, D; Han, Y; Li, R; Li, W; Liu, J; Xin, A; Yan, Q; Zhang, Y | 1 |
| Endo, T; Hojo, H; Imai, Y; Kondo, Y; Nozoe, S | 1 |
2 other study(ies) available for corydine and Experimental Neoplasms
| Article | Year |
|---|---|
Design, synthesis, and anticancer properties of isocorydine derivatives.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aporphines; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Mice; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship | 2017 |
Suppression of tumor cell growth and mitogen response by aporphine alkaloids, dicentrine, glaucine, corydine, and apomorphine.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antitussive Agents; Apomorphine; Aporphines; Cell Division; Colonic Neoplasms; Evaluation Studies as Topic; Immunosuppressive Agents; Leukemia L1210; Leukemia P388; Lymphocyte Activation; Male; Melanoma, Experimental; Mice; Mitogens; Neoplasms, Experimental; Urinary Bladder Neoplasms | 1990 |